ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2020 American Transplant Congress

    Improvement in Long Term Kidney Transplant Survival Most Dramatic among Minorities, Diabetics and Older Patients

    E. D. Poggio1, S. Arrigain2, A. Wee3, D. C. Brennan4, J. D. Schold2

    1Nephrology, Cleveland Clinic, Cleveland, OH, 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 3Urology, Cleveland Clinic, Cleveland, OH, 4Nephrology, Johns Hopkins, Baltimore, MD

    *Purpose: Short-term and long-term kidney transplant graft survival has been improving over time, but whether this improvement in outcomes is more pronounced in the early…
  • 2020 American Transplant Congress

    Automated Monitoring of Four Urinary Biomarkers in Routine Surveillance Identifies Patients at Low and High Risk of Renal Allograft Injury

    L. Sheward1, J. Wedel1, N. Rodig1, R. Mannon2, O. Bestard3, V. Dharnidharka4, D. Zurakowski1, A. Kho1, T. Blydt-Hansen5, M. Seifert2, D. M. Briscoe1

    1Boston Children's Hospital, Boston, MA, 2University of Alabama at Birmingham, Birmingham, AL, 3Bellvitge University Hospital, Barcelona, Spain, 4St Louis Children's Hospital, St Louis, MO, 5BC Children's Hospital, Vancouver, BC, Canada

    *Purpose: Surveillance renal biopsy data indicate that up to 36% of clinically stable kidney allograft recipients have subclinical rejection, emphasizing the need to implement automated…
  • 2020 American Transplant Congress

    Temporal Trends in Utilization and Outcomes of Sclerotic Donor Kidneys in the United States

    J. D. Motter, K. R. Jackson, J. J. Long, A. B. Massie, N. M. Desai, D. L. Segev, J. M. Garonzik-Wang

    Johns Hopkins University, Baltimore, MD

    *Purpose: Sclerotic donor kidneys (SDK, glomerulosclerosis ≥20% on biopsy) represent a possible expansion to the donor pool but are often discarded due to historical association…
  • 2020 American Transplant Congress

    Conversion to Sirolimus to Prevent Recurrent Cytomegalovirus Infection/Disease: A Prospective and Randomized Trial

    L. Almeida Viana, M. Pontello Cristelli, G. Basso, D. Wagner Castro Lima Santos, M. Taver Costa Dantas, Y. Cardoso Dreige, L. Damasceno, M. Rika Nakamura, H. Tedesco-Silva, J. Medina-Pestana

    Hospital do Rim - UNIFESP, São Paulo, Brazil

    *Purpose: Recurrent cytomegalovirus (CMV) infection occurs in 30-35% of kidney transplant recipients after completion of treatment and/or preemptive therapy. There is no consensus on the…
  • 2020 American Transplant Congress

    Belatacept Provides Superior Inhibition of Donor Specific Antibody Formation in Kidney Transplant Recipients with Acute Rejection

    O. Cristea, C. Larsen, I. Badell

    Emory Transplant Center, Emory University School of Medicine, Atlanta, GA

    *Purpose: The factors responsible for chronic renal allograft dysfunction and premature graft loss are incompletely understood and likely multifactorial. Immunologic injury partially attributable to the…
  • 2020 American Transplant Congress

    The Role of the Molecular Microscope to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants

    D. Kumar1, M. Demehin1, J. Christensen1, L. Kamal1, I. Moinuddin1, M. Levy1, C. Bhati1, A. King1, H. D. Massey1, P. Halloran2, G. Gupta1

    1Virginia Commonwealth University, Glen Allen, VA, 2ATAGC, Edmonton, AB, Canada

    *Purpose: Histologic lesions (I+T) to characterize T-cell mediated rejection (TCMR) can be non-specific. In some cases the inflammation may represent a ‘response to wounding’ rather…
  • 2020 American Transplant Congress

    Anti-HLA IgM Antibodies are Unaffected by Imlifidase (IdeS) Treatment

    A. Runström1, R. Bockermann1, K. Sjöholm1, K. M. Roupé1, Å. Schiött1, L. Winstedt1, C. Kjellman1, T. Lorant2

    1Hansa Biopharma AB, Lund, Sweden, 2Section of Transplantation Surgery, Department of Surgical Sciences, Uppsala, Sweden

    *Purpose: The immunoglobulin G (IgG)-degrading cysteine protease, imlifidase (IdeS) is an IgG endopeptidase under development as a rapid desensitization treatment in kidney transplantation. Imlifidase is…
  • 2020 American Transplant Congress

    Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, 2Pharmacy, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: We have previously reported that favorable short-term outcomes of kidney recipients were achieved by corticosteroid early withdrawal protocol (CSEW) compared to the conventional protocol…
  • 2020 American Transplant Congress

    Paired-Donor Kidney Exchange Has Comparable Early Graft Function to Directed Living Donor

    E. McCracken, A. Sites, B. Rawashdeh, A. Nishio-Lucar, A. Agarwal

    Transplant Surgery, University of Virginia, Charlottesville, VA

    *Purpose: Living kidney donation in the United States is associated with improved graft and patient survival. However, there is minimal data on graft function in…
  • 2020 American Transplant Congress

    Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes

    H. Crossman1, M. Tavakol2, C. Freise2, P. Chin-Hong3

    1Internal Medicine Residency Program, UCSF, San Francisco, CA, 2Surgery, UCSF, San Francisco, CA, 3Infectious Disease, UCSF, San Francisco, CA

    *Purpose: Increased utilization of hepatitis C virus infected organs could reduce the supply demand mismatch in organ transplantation. At this time, there is little data…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences